Dr. Ken Shain is organizing multiple myeloma OncLive event (State of the Science SUMMIT) in Tampa!! OncLive SOSS Moffitt Cancer Center

Very nice myeloma sessions organized by Dr. Shain tonight!! Thank you OncLive SOSS

APPLY NOW: Moffitt’s Behavioral Oncology T32 Program provides outstanding postdoctoral training with exceptional mentors & learning opportunities. The program has graduated over 40 trainees to date. To learn more, visit: bit.ly/3NfgHnP

📣 We're #Hiring! At EBMT we are always looking for 🔝 #talent! 💪 Want to join our dynamic team and work for a non-profit? 🔬⚕️ If you want to know more 🙋‍♀️🙋‍♂️ browse our open positions and #applynow via ➡ careers.ebmt.org

The Machine Learning Department at Moffitt Cancer Center has available opportunities. Please click moffitt.org/research-scien…… to view more information. #machinelearning

Faculty position is open for a myeloma specialist to join Moffitt myeloma team! …nter-careers-internal.hctsportals.com/jobs/1606860-m…

We are expanding! Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT) at Moffitt has positions open for transplant physicians specializing in myeloid disorders. …nter-careers-internal.hctsportals.com/jobs/1217283-b…

Exciting opportunities! Moffitt BMT CI has positions open for Advanced Practice Professionals (APPs: physician assistants (PAs) and nurse practitioners (NPs)) taking care of patients undergoing transplant and CAR T cell therapy. Please apply! …nter-careers-internal.hctsportals.com/jobs/1579752-n…

If you are a pharmacist and interested in CAR T and BMT, please apply! Moffitt has an open position for Clinical Pharmacy Specialist in BMT CI department. Here's the info. …cancer-center-careers.hctsportals.com/jobs/1516185-c…

Hurricane Idalia ride-out team for Moffitt BMT CI, "Team A" - Stay safe everyone!

Time to vote for the ASTCT Board of Directors! Familiar names are on the ballot - our chair, Frederick L. Locke, and our former team member, Mohamed Kharfan-Dabaja, MD, MBA at MCC. Please vote!!

Just finished 10K TCMS Trot thru the Terrace!

Miles for Moffitt Cancer Center 10 K completed!

"It is not out of the realm of possibility that one or two out of 10,000 patients could develop T-cell lymphoma." -- Frederick L. Locke, of Moffitt Cancer Center, discussing the FDA's investigation of malignancy after autologous CAR T-cell therapies. MedPage Oncology medpagetoday.com/hematologyonco…

For our patients/families, still have time to register for tomorrow's BMT survivorship educational event (nutrition & physical wellness)! eventactions.com/eareg.aspx?ea=…

Look who was granted for 1-day (Friday) admission to Tandem 2024! Julio Chavez

CALL FOR EDITOR NOMINATIONS ASH seeks Editors-in-Chief (two inaugural) to lead four journals: Blood, Blood Erythrocytes-NEW, Blood Immunology & Cellular Therapy-NEW, and Hematology: The ASH Education Program. ow.ly/xxkH50QAMJh

At #Tandem24, J Holter Chakrabarty & Taha A, MD interviewed Becky Dame of The Leukemia & Lymphoma Society. Becky is a 2x transplant recipient & has battled #GVHD. In this video, she shares her thoughts on the #GVHDAlliance & more. 🎤 View the interview on Nucleus: ow.ly/aS1C50QIxy1 #RareDiseaseDay

Asparaginase-associated hypertriglyceridemia is probably well known but it could produce impressively high TG levels in like 1000s... pubmed.ncbi.nlm.nih.gov/9058708/ pubmed.ncbi.nlm.nih.gov/34511319/

BMT CI is hosting the patient reunion, and we are looking for sponsors for the event celebrating our program's 35th anniversary. If anyone is interested, please follow the link below. Our patients will be appreciative of any help! moffitt.org/treatments/blo…